ArticleFrontiers in oncology2026
Case Report: Occult mantle cell lymphoma in a synchronous rectal collision tumor with adenocarcinoma: retrospective reclassification and multispecimen molecular profiling.
Article in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Collision tumors composed of colorectal adenocarcinoma and mantle cell lymphoma are exceptionally rare, and component-resolved molecular characterization is largely lacking. We report a 65-year-old woman who initially presented with rectal adenocarcinoma and underwent radical resection followed by adjuvant capecitabine. Seven months later, she developed generalized lymphadenopathy, and excisional cervical lymph node biopsy confirmed mantle cell lymphoma with Cyclin D1 and SOX11 positivity, t(11;14)(q13;q32) rearrangement, and a Ki-67 proliferation index of approximately 40%. Retrospective review of the original rectal resection specimen identified an occult mantle cell lymphoma component at the tumor margin and within the submucosa, leading to reclassification as a synchronous rectal collision tumor composed of adenocarcinoma and mantle cell lymphoma. Targeted sequencing across four specimens revealed a shared TP53 exon 7 frameshift in the archival composite rectal specimen, the rectal lymphoma component, and the adenocarcinoma component, whereas the nodal lymphoma specimen showed a dominant NOTCH2-truncating profile without a reported pathogenic TP53 alteration. The adenocarcinoma component additionally harbored a truncating APC alteration consistent with colorectal tumorigenesis. These findings support partial molecular overlap together with compartment- and site-specific divergence, while not establishing a common clonal origin. The patient received bendamustine plus rituximab followed by zanubrutinib maintenance and remained in remission at the last follow-up. This case highlights a clinically important diagnostic pitfall, shows how retrospective pathologic review can uncover occult gastrointestinal mantle cell lymphoma in a colorectal resection specimen, and provides multi-specimen molecular evidence of spatial heterogeneity across synchronous bowel and nodal disease.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.